Universe Pharmaceuticals Inc. reported its financial results for the six months ended March 31, 2025. The company experienced a significant decrease in revenues, which fell by 29.0% to $9.2 million from $12.9 million in the same period the previous year. This decline in revenue was primarily attributed to a decrease in the average selling price and sales volume of the company's third-party products. The company also reported a net loss of $3.3 million, an increase of 37.4% from the net loss of $2.4 million recorded in the same period of 2024. The loss from operations was $2.3 million, up from $1.7 million in the prior year, due to reduced revenue and increased general and administrative expenses. There was no specific outlook or guidance provided in the report.